1B-LSD Blotters 125mcg research material from Raw Lab Chems
1B-LSD Blotters - 125mcg Price range: € 31,75 through € 370,00
Back to products
AL-LAD Blotters 150mcg research material from Raw Lab Chems
AL-LAD Blotters - 150mcg Price range: € 44,75 through € 560,00

Buy 1cP-MiPLA Blotters – 200mcg

Price range: € 43,30 through € 515,00

1cP-MiPLA Blotters 200mcg are described as blotter-paper research preparations associated with 1-cyclopropionyl-N-methyl-N-isopropyl-lysergamide, a synthetic lysergamide structurally related to LSD and MiPLA.

The named compound combines an N1-cyclopropionyl substituent with an N-methyl-N-isopropylamide group.

The supplied source identifies individual blotter squares with a labeled analyte quantity, intended for controlled analytical and non-clinical laboratory research.

Relevant scientific contexts include chemical identity assessment, chromatographic characterization, structural comparison, and investigation of related lysergamides.

The source reports two conflicting CAS identifiers and a molecular formula of C24H29N3O2.

Its stated molecular weight of approximately 454.5 g/mol does not match that formula.

The source also refers to HPLC, GC-MS, NMR, or LC-MS verification, batch identification, and Certificate of Analysis documentation.

However, no actual batch-specific analytical report or supporting certificate was supplied.

Ingredient purity, finished-unit analyte content, content uniformity, blotter-substrate composition, chemical form, and storage stability remain unverified.

The blotters are not established as certified reference materials or validated quantitative calibration standards.

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

SKU: CERT-P-12850 Category:
Description

1cP-MiPLA Blotters 200mcg – Cyclopropionyl Lysergamide Research Material

1cP-MiPLA Blotters 200mcg – Product Overview

1cP-MiPLA Blotters 200mcg is the supplied catalog designation for a blotter-format research preparation associated with 1-cyclopropionyl-MiPLA.

The named compound belongs to the lysergamide family and is structurally related to LSD and MiPLA.

Its molecular structure is described as incorporating an N1-cyclopropionyl group together with an N-methyl-N-isopropylamide substituent.

The supplied source presents the product as individual blotter-paper squares intended for controlled analytical and non-clinical laboratory research.

Each finished blotter is described as having a labeled analyte quantity.

However, no actual finished-unit assay or content-uniformity report accompanied the information.

The labeled quantity therefore remains a source-provided specification rather than an independently verified analytical result.

The supplied scientific context includes chemical identification, chromatographic characterization, structural comparison, and stability-focused investigation.

These research contexts should be distinguished from verified findings about the actual finished blotters.

No batch-specific analytical identity certificate, impurity profile, or validated assay result was provided.

The source also refers to HPLC, GC-MS, NMR, or LC-MS verification, batch identification, and Certificate of Analysis documentation.

These statements remain unverified without supporting records.

The finished preparation is not established as a certified reference material, validated quantitative calibrator, or approved pharmaceutical product.

Chemical Identity & Classification

The supplied source identifies 1cP-MiPLA as 1-cyclopropionyl-N-methyl-N-isopropyl-lysergamide.

It is described as a synthetic lysergamide structurally related to MiPLA and LSD.

The N1-cyclopropionyl group and the N-methyl-N-isopropylamide substituent distinguish the named compound from related lysergamides.

The supplied chemical information includes:

  • Common designation: 1cP-MiPLA
  • Descriptive chemical name: 1-Cyclopropionyl-N-methyl-N-isopropyl-lysergamide
  • Alternative description: 1-Cyclopropionyl-lysergic acid N,N-methylisopropylamide
  • Reported CAS Registry Numbers: 3028950-74-2 and 2028950-74-2; conflicting source identifiers
  • Reported molecular formula: C24H29N3O2
  • Calculated molecular weight from reported formula: Approximately 391.51 g/mol
  • Source-stated molecular weight: Approximately 454.5 g/mol; inconsistent with the reported formula
  • Chemical classification: N1-acylated lysergamide
  • Reported presentation: Blotter-paper squares
  • Labeled analyte amount: Specified per finished blotter
  • Intended designation: Research Use Only

The source includes a proposed systematic chemical name, but no verified structural record or stereochemical assignment was supplied.

The conflicting CAS identifiers require resolution before either is published as a definitive identifier.

The reported formula and stated molecular weight are not internally consistent.

The source does not establish whether the stated molecular weight refers to a different chemical form or is an error.

No verified salt-form determination or complete stereochemical characterization was supplied.

The molecular structure of the named compound does not establish the composition of the finished blotter preparation.

Additional substrate materials or formulation components may be present, but the source does not identify them.

Researchers may consult PubChem for public chemical-reference information, ensuring that any selected database entry corresponds to the actual molecular structure, stereochemistry, and chemical form being examined.

Chemical & Physical Characteristics

The supplied source describes the product as small blotter-paper squares with grid-like markings.

No actual product-specific physical inspection report, image verification, or batch appearance record was supplied.

A blotter is a finished preparation in which the named analyte is associated with a carrier substrate.

The characteristics of the complete preparation therefore differ from those of the isolated chemical compound.

The source does not identify the substrate composition, blotter dimensions, total unit mass, manufacturing method, or surface characteristics.

The named compound is described as containing an N1-cyclopropionyl group and an N-methyl-N-isopropylamide substituent.

These structural features distinguish 1cP-MiPLA from MiPLA and other related lysergamides.

The source also claims solubility in ethanol, methanol, acetonitrile, and DMSO, together with limited water solubility.

However, no experimentally verified solubility measurements, substrate-extraction studies, or product-specific solvent compatibility records were supplied.

These statements should not be treated as validated extraction or analytical recovery characteristics of the finished blotters.

The source does not establish the distribution of analyte across the blotter substrate.

Consequently, the properties of the isolated compound should not be assumed to describe the complete finished unit.

Purity & Analytical Verification

The supplied source refers to a typical ingredient purity of approximately 97–99% where verified.

However, no actual batch-specific Certificate of Analysis or laboratory report accompanied that statement.

The reported purity range therefore remains a supplier-provided claim rather than an independently verified result.

The source refers to HPLC, GC-MS, NMR spectroscopy, and LC-MS as analytical verification methods.

No chromatogram, mass spectrum, NMR spectrum, impurity profile, or independent laboratory certificate was supplied.

Accordingly, no specific purity result can be confirmed for the actual product batch.

For 1cP-MiPLA Blotters 200mcg, the chemical purity of the named ingredient and the actual analyte quantity in each finished unit are separate analytical characteristics.

An ingredient-purity result does not independently establish finished-unit content or content uniformity.

The source also does not establish whether any claimed purity measurement applies to isolated bulk material or the complete finished preparation.

The material is described in reference-oriented research terms.

However, no certified reference-material documentation, assigned measurement value, uncertainty statement, or metrological traceability record was supplied.

The finished blotters should therefore not be represented as certified quantitative reference standards.

Any definitive analytical claims require actual supporting batch records.

Quality Control & Batch Integrity

The supplied source refers to batch identification, analytical verification, and Certificate of Analysis documentation.

These statements describe proposed or claimed quality-assurance practices.

No actual certificate, independent testing report, manufacturing audit, or batch-specific quality-control record accompanied the information.

They therefore remain unverified supplier claims.

For reproducible analytical documentation, relevant records may include verified chemical identifiers, confirmed stereochemical composition where available, batch number, analytical findings, receipt date, and available storage history.

For 1cP-MiPLA Blotters 200mcg, the identity and purity of the named compound should be distinguished from the composition and consistency of the finished units.

The supplied information does not establish independently verified analyte content, substrate composition, or content uniformity.

The source also does not provide evidence that every finished blotter meets a particular quantitative specification.

The Research Use Only designation describes intended positioning but does not independently demonstrate manufacturing quality or analytical traceability.

Claims concerning batch consistency and validated analytical performance should be supported by actual records.

Safety, Handling & Laboratory Precautions

1cP-MiPLA is described as a synthetic lysergamide with potential pharmacological activity and significant toxicological uncertainty.

The supplied source does not provide a complete product-specific toxicological assessment.

Laboratory personnel should consult applicable chemical-safety documentation and institutional procedures before receiving or examining the material.

Relevant precautions include restricted access, appropriate protective equipment, contamination prevention, accidental-exposure procedures, and chemical-waste management.

The blotter presentation does not establish safety for human or veterinary exposure.

The material should remain secured against unauthorized access and separated from food, beverages, and non-research environments.

Because the actual chemical form, ingredient purity, substrate composition, and finished-unit content have not been independently confirmed, laboratory documentation should distinguish verified characteristics from supplier-provided statements.

Any accidental exposure or contamination incident should be managed according to institutional emergency procedures.

Packaging, Labeling & Storage

The supplied source describes discreet packaging, batch-aware handling, tracking, and protective shipment arrangements.

No actual packaging specification, container-validation report, or shipment-condition record was provided.

The source recommends storage in a sealed, moisture-resistant container in a cool, dry environment protected from light.

It also suggests refrigeration at approximately 2–8°C.

No validated product-specific stability study was supplied to establish that temperature range as a verified requirement or to support a particular shelf life.

For 1cP-MiPLA Blotters 200mcg, laboratory inventory records should preserve the product designation, any available batch identifier, receipt details, and relevant storage observations.

The labeled analyte quantity should be recorded as a source-provided specification unless independently verified.  1cP-MiPLA Blotters 200mcg

Packaging and environmental requirements should be assessed using available safety documentation, relevant stability evidence, and institutional procedures.

Intended Research Use & Market Positioning

The supplied scientific context places 1cP-MiPLA within analytical research involving lysergamide chemical identity, N1-acyl substitution, and comparative structural characterization.

The cyclopropionyl group and the N-methyl-N-isopropylamide substituent provide distinguishing structural features relevant to chemical analysis.

The source also describes interest in chromatographic profiling, forensic analytical characterization, and stability-focused laboratory research.

However, no product-specific analytical validation, receptor-binding dataset, or stability study was supplied for the actual blotters.  1cP-MiPLA Blotters 200mcg

The Raw Lab Chems catalog identifies 1cP-MiPLA Blotters as the product listing discussed here.

For related chemical-family context, the supplied catalog also includes AL-LAD Blotters and LSZ Blotters.

These listings refer to distinct lysergamide compounds or preparations.

1cP-MiPLA, AL-LAD, and LSZ should not be treated as chemically identical or analytically interchangeable.

The supplied information does not establish equivalent chemical purity, analyte content, substrate composition, or content uniformity across these preparations.

These catalog references should not be interpreted as evidence of certified reference-material status or validated quantitative equivalence.

Ordering, Availability & Fulfillment

The supplied source describes protective packaging, international shipping, tracking, and secure handling arrangements.

It also identifies possible labeled pack sizes.

No current inventory record, confirmed pack-size listing, carrier agreement, shipment authorization, or verified delivery information was supplied.

Consequently, no availability, pack-size, delivery-time, customs-clearance, or transportation-compliance guarantee is asserted.  1cP-MiPLA Blotters 200mcg

1cP-MiPLA may be subject to controlled-substance, analogue, pharmaceutical, or other chemical regulations depending on the jurisdiction.

Institutional acquisition, possession, transportation, importation, and exportation must be assessed under applicable laws.

Research-only labeling does not establish a legal exemption.

Legal & Regulatory Disclaimer

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

1cP-MiPLA is described as a synthetic lysergamide whose possession, acquisition, transfer, transportation, importation, exportation, and laboratory investigation may be restricted or prohibited depending on the jurisdiction. 1cP-MiPLA Blotters 200mcg

The supplied information does not establish universal legal status or regulatory authorization.

Institutions remain responsible for determining applicable legal requirements and obtaining any necessary permissions.

No medical approval, consumer-use authorization, or regulatory exemption is implied by this description.

Additional information
Quantity (blotters)

5

,

10

,

25

,

50

,

100

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Buy 1cP-MiPLA Blotters – 200mcg”
Shipping & Delivery